Related Experiment Videos
mTORC2 Signaling: A Path for Pancreatic β Cell's Growth and Function
Ting Yuan1, Blaz Lupse1, Kathrin Maedler1
1University of Bremen, Centre for Biomolecular Interactions Bremen, Bremen, Germany.
Journal of Molecular Biology
|February 27, 2018
Summary
Mechanistic target of rapamycin complex 2 (mTORC2) is crucial for pancreatic beta-cell function and mass. Declines in mTORC2 accelerate type 2 diabetes by impairing insulin secretion and beta-cell survival.
Area of Science:
- Cellular signaling pathways
- Metabolic regulation
- Endocrinology
Background:
- The mechanistic target of rapamycin (mTOR) pathway regulates cell growth and metabolism via mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2).
- While mTORC1 is well-studied in beta-cells, mTORC2's role in pancreatic beta-cell function and mass is emerging.
- mTORC2 signaling is reduced in beta-cells during type 2 diabetes.
Purpose of the Study:
- To review the role of mTORC2 in regulating pancreatic beta-cell function and mass.
- To highlight mTORC2's contribution to glucose metabolism and beta-cell homeostasis.
- To discuss mTORC2's significance in type 2 diabetes pathophysiology.
Main Methods:
- Literature review of recent advances in mTORC2 signaling.
- Analysis of mTORC2's impact on beta-cell biology.
- Examination of mTORC2 targets and their role in diabetes.
Main Results:
- Beta cell-selective mTORC2 inactivation impairs glucose tolerance and accelerates diabetes.
- Reduced beta-cell mass, proliferation, and insulin secretion are consequences of mTORC2 deficiency.
- mTORC2 targets like AKT and FOXO1 are vital for beta-cell survival and function.
Conclusions:
- mTORC2 is essential for maintaining beta-cell homeostasis and compensatory responses.
- Dysregulation of mTORC2 contributes to the pathogenesis of type 2 diabetes.
- Targeting mTORC2 signaling may offer therapeutic strategies for type 2 diabetes.